Peter Hofsteen

Peter Hofsteen has worked in a variety of roles in the scientific field since 2006. Peter began their career as a Research Associate in Toxicology at Astellas Pharma US. In 2007, they moved to Amylin Pharmaceuticals as a Study Director in Drug Delivery/PK. After that, they worked at BTS Research as a Project Manager, Study Director, and Scientific Contributor from 2008 to 2009. Peter then moved to the University of Wisconsin-Madison as a Graduate Research Assistant in Developmental Biology and Toxicology from 2009 to 2013. After that, they worked as a Senior Research Scientist in Bioassay Development at Promega Corporation from 2018 to 2022. Most recently, they have been a Senior Scientist II in Discovery at Invenra since 2022.

Peter Hofsteen has a Postdoctoral fellowship from the University of Washington, which they completed in 2017. Peter also holds a PhD in Pharmaceutical Sciences from the University of Wisconsin-Madison, which they obtained in 2013.